Work

The Growing Burden of Major Depressive Disorders (MDD): Implications for Researchers and Policy Makers

Year: 2021
Type: editorial
Abstract: Major Depressive Disorder (MDD) is one of the most burdensome illnesses globally, with significant negative impacts on activities of daily living, quality of life, cognitive function, and employment status and work productivity [1,2].Researchers studying MDD are challenged by the complex nature of the disease, which is often comorbid with other chronic and acute conditions, including both physical and psychiatric disorders.In particular, the treatment pathway for patients with MDD is remarkably complicated, with extensive variability in disease presentation, uncertainty of diagnoses, and heterogeneity of treatment effects.The research featured in this special issue of Pharma-coEconomics draws on findings from a variety of countries across North America, Europe, Asia, and Oceania.Although differences in culture as well as health and social care systems complicate research in MDD, a broad survey of studies of the burden of MDD provides an opportunity for new insights concerning the many determinants of health outcomes associated with this disease.This editorial overview surveys these studies, focusing on several unifying themes:1. Growing prevalence of MDD, particularly during the coronavirus disease 2019 (COVID-19) pandemic 2. Research concerning the cost of MDD 3. Economic burden of MDD in subpopulations 4. Advances in analytical methods 5. Implications for researchers and policy makers.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,860
OpenAlex ID: W3163489461
Cites: 19
Cited by: 243
Related to: 10